Acknowledging the kind of traction gained by this market, recently published a study report by industry data analytics asserts the Global Autoimmune Disease Diagnosis Market size is projected to accrue voluminously by 2027 registering a phenomenal CAGR of 8.12% during the review period (2022 to 2027).
The autoimmune disease diagnosis market consists of sales of diagnostic tests and related facilities by objects (organizations, sole traders and partnerships) that are used for the diagnosis of autoimmune illnesses. Autoimmune diseases are the diseases in which the production of antibodies takes place in the body which attack and destroy the patient's own healthy cells in the body. These include Crohn's disease, rheumatoid arthritis, Hashimoto's disease, many sclerosis, Grave's disease, psoriasis, coeliac disease, type 1 diabetes, lupus and inflammatory bowel syndrome, and are identified by immunological tests. Autoimmune diseases occur when the immune system attacks one or more cells of the body which are functioning normally owed to the irregularities. The mis-functioning of resistant system is a result of the failure to recognize immune cells, tissues and organs and producing autoantibodies targeting these cells. According to The National Institutes of Health (NIH) 23.5 million Americans are affected by this illness in the year 2015.
The Global Autoimmune Disease Diagnosis Market includes identification and analysis of the various market participants competing in the global market. Prime competitors include Fisher Scientific (US), Siemens (Germany), Abbott (US), Danaher (US), Bio-Rad Laboratories (US), Grifols (Spain), Trinity Biotech (Ireland), Werfen (Spain), HYCOR Biomedical (US), EUROIMMUN AG (Germany), Oncimmune (UK), HTG Molecular Diagnostics (US), Seramun Diagnostica GmbH (Germany), Exagen Inc. (US), Cambridge Life Sciences Limited (UK), A. Menarini Diagnostics s.r.l (Italy), ORGENTEC Diagnostika (Germany), KRONUS (US), and AESKU.GROUP GMBH & CO. KG (Germany).
Oct. 15, 2019: HTG Announces the Launch of its New Autoimmune Profiling Assay
HTG Molecular Diagnostics, Inc. (Nasdaq: HTGM) (HTG), a diagnostic company whose mission is to advance precision medicine, today announced it will begin taking orders for its new 2,002-gene HTG EdgeSeq Autoimmune Panel, which is expected to be commercially available for purchase in kit form or as a service in HTG’s VERI/O laboratory at the end of October 2019
Market is segmented based on the type, applications, companies and regions.
By Type, it is segmented into
By End user, it is segmented into
North America held the largest market share of over 40.0% in 2015, majorly due to the introduction of the Affordable Care Act, the presence of favorable regulations & initiatives undertaken by the AARDA, and high disease prevalence in the region. Asia Pacific region is expected to witness lucrative growth due to constantly improving healthcare infrastructure, growing patient awareness levels, and the presence of high unmet patient needs. It is expected to experience an increase in revenue share during the forecast period. Its market share is anticipated to grow from 21.0% in 2015 to over 22.0% in 2025.
The Global Autoimmune Disease Diagnosis Market describes the factors driving the global growth opportunities in upcoming years and highlights market channels. In addition, the report analyzes market size and share, trends, by geographic region, end-use type and segment. It focuses extensively on revealing a detailed regional analysis. The Global Autoimmune Disease Diagnosis Market report also conducted a PESTEL analysis of the industry to study the main influencing factors and entry barriers of the industry.
Report Attributes | Report Details |
Forecast Period 2022 to 2028 CAGR | CAGR of 8.12% during the review period (2022 to 2027). |
By Types |
|
By End user |
|
By Companies | Fisher Scientific (US), Siemens (Germany), Abbott (US), Danaher (US), Bio-Rad Laboratories (US) |
Regions Covered |
|
Countries Covered |
|
Base Year | 2022 |
Historical Year | 2017 to 2021 |
Forecast Year | 2022 to 2027 |
Number of Pages | 101 |
Customization Available | Yes, the report can be customized as per your needs |
What is the study period of this market?
The Global Autoimmune Disease Diagnosis Market is studied from 2022-2027.
Who are the prime players in the Global Autoimmune Disease Diagnosis Market?
Fisher Scientific (US), Siemens (Germany), Abbott (US), Danaher (US), Bio-Rad Laboratories (US),
Which region held the largest share in the Global Autoimmune Disease Diagnosis Market?
United States, Europe, China, Japan, Southeast Asia, India and Rest of World
What are the significant Types of Global Autoimmune Disease Diagnosis Market?
Routine Laboratory Tests, Inflammatory Markers, Autoantibodies & Immunologic Test, Other Tests
What are the major End use of Global Autoimmune Disease Diagnosis Market?
Clinical Laboratories, Hospitals, Other End Users
SECONDARY RESEARCH
Secondary Research Information is collected from a number of publicly available as well as paid databases. Public sources involve publications by different associations and governments, annual reports and statements of companies, white papers and research publications by recognized industry experts and renowned academia etc. Paid data sources include third party authentic industry databases.
PRIMARY RESEARCH
Once data collection is done through secondary research, primary interviews are conducted with different stakeholders across the value chain like manufacturers, distributors, ingredient/input suppliers, end customers and other key opinion leaders of the industry. Primary research is used both to validate the data points obtained from secondary research and to fill in the data gaps after secondary research.
MARKET ENGINEERING
The market engineering phase involves analyzing the data collected, market breakdown and forecasting. Macroeconomic indicators and bottom-up and top-down approaches are used to arrive at a complete set of data points that give way to valuable qualitative and quantitative insights. Each data point is verified by the process of data triangulation to validate the numbers and arrive at close estimates.
EXPERT VALIDATION
The market engineered data is verified and validated by a number of experts, both in-house and external.
REPORT WRITING/ PRESENTATION
After the data is curated by the mentioned highly sophisticated process, the analysts begin to write the report. Garnering insights from data and forecasts, insights are drawn to visualize the entire ecosystem in a single report.
Reach us with your research requirements and we shall provide the optimum solution to suit your needs.
Discounts available for multiple report purchases.